Publications
5539 Results
- Journal / Conference
- Blood 100(13):4298-4302
- Year
- 2002
- Research Committee(s)
- Leukemia
- Study Number(s)
- SWOG-9129 (INT-0129)
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol
- Journal / Conference
- The Journal of Infectious Diseases 186:15-22
- Year
- 2002
Dynamics of CD4 and CD8 T cell responses to cytomegalovirus in healthy human donors
- Journal / Conference
- Journal of Immunotherapy 25(2):97-138
- Year
- 2002
Immunologic monitoring of cancer vaccine therapy: results of a workshop sponsored by the Society for Biological Therapy
- Journal / Conference
- Journal of Immunotherapy 25(6):S33
- Year
- 2002
Generation of iTAg tetramer binding CD8 T cells using antigen presenting cells derived from PBMC under different culture conditions
- Journal / Conference
- Blood 100(11):198a(#743)
- Year
- 2002
- Research Committee(s)
- Leukemia
- Study Number(s)
- C19801
A phase II study of 2-amino-9-B-D-arabinosyl-6-methoxy-9H-purine (506U78) in patients with relapsed or refractory T-lineage acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma (LBL): CALGB study 19801.
- Journal / Conference
- Blood 100(11):210a(#790)
- Year
- 2002
- Research Committee(s)
- Leukemia
Time to first progression is the best predictor of survival duration in SWOG standard dose chemotherapy studies
- Journal / Conference
- Int J Radiat Oncol Biol Phys 54(2):103-104(#174)
- Year
- 2002
- Research Committee(s)
- Lung
Analysis of prognostic factors in Southwest Oncology Group stage III non-small cell lung cancer trials requiring pre-treatment histological assessment of mediastinal lymph nodes
- Journal / Conference
- Int J Radiat Oncol Biol Phys 54(2):2(#3)
- Year
- 2002
- Research Committee(s)
- Head and Neck
- Study Number(s)
- SWOG-9515 (RTOG-9501)
Patterns of failure for resected advanced head & neck cancer treated by concurrent chemotherapy and radiation therapy: an analysis of RTOG 9501/Intergroup Phase III trial
- Journal / Conference
- Journal of Clinical Oncology 20(8):2209-2210
- Year
- 2002
- Research Committee(s)
- Melanoma
- Study Number(s)
- SWOG-9512 (E1694)
In reply to the Letter to the Editor: Sentinel-node technique will change the design of clinical trials in malignant melanoma
- Journal / Conference
- Blood 100(11):598a(#2351)
- Year
- 2002
- Research Committee(s)
- Myeloma
- Study Number(s)
- SWOG-9321